Picture of Ind Swift logo

INDSWFTLTD Ind Swift Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-4.84%
3m-44.38%
6m-28.86%
1yr-47.89%
Volume Change (%)
10d/3m-82.86%
Price vs... (%)
52w High-62.54%
50d MA-6.82%
200d MA-38.26%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.3%
Return on Equityn/a
Operating Margin3.21%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m3,295.23,560.593,977.144,109.585,022.48n/an/a11.68%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Ind Swift EPS forecast chart

Profile Summary

Ind Swift Limited is an India-based company, which is engaged in manufacturing and trading of pharmaceutical and healthcare products. The Company's divisions include Nova Division, Ethical Division, Generic Division, and Ayurveda Division. The Nova Division is a multispecialty division. Its portfolio covers all the therapeutic segments which are available in all the other divisions like respiratory inclusive of ENT, dentistry, anti-infective, cardio-diabetic and orthopedic therapies. The Nova Division Products include Aclovin, Aclovin - SR, Adelive oil and Agipod D/S. The Ethical Division is focused on gynecology, pediatrics, dermatology and GP and its ambit extends to a wide range of medicines. The Generic Division is divided into various therapeutic segments, namely antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial and anti-depressants. The Ayurveda Division's products include Swift Hangover Capsules, Oliade Oil, Swift Tulsi Drops and Majitrich Capsules.

Directors

Last Annual
March 31st, 2024
Last Interim
December 31st, 2024
Incorporated
June 6th, 1986
Public Since
July 29th, 1994
No. of Employees
1,670
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
54,164,653

INDSWFTLTD Share Price Performance

Upcoming Events for INDSWFTLTD

Q4 2025 Ind Swift Ltd Earnings Release

Q1 2026 Ind Swift Ltd Earnings Release

Ind Swift Ltd Annual Shareholders Meeting

Similar to INDSWFTLTD

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ